“Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis”, jkcvhl, vol. 4, no. 1, pp. 8–15, Mar. 2017, doi: 10.15586/jkcvhl.2017.59.